Prometic Life Sciences Inc., of Laval, Quebec, said it received a notice of exercise of the overallotment option to acquire an additional 1.98 million shares priced at $1.90 apiece for gross proceeds of $3.8 million, from the syndicate of underwriters led by Canaccord Genuity Corp. and including Paradigm Capital Inc., RBC Capital Markets and Beacon Securities Ltd.